Scarica l'app Stockscreener
29.30
0.43%
-0.27
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ADPT Giù?
Forum
Previsione
Adaptive Biotechnologies Corp Borsa (ADPT) Ultime notizie
Adaptive Biotechnologies (ADPT) Jumped, So What Is Driving Attention Now? - Yahoo Finance
Adaptive Biotechnologies Corp (ADPT) Stock Up 6.0% but GF Value Says Overvalued -- GF Score: 68/100 - gurufocus.com
Adaptive Biotechnologies (NASDAQ:ADPT) Stock Price Up 4.4%Should You Buy? - MarketBeat
Adaptive Biotechnologies stock hits 52-week high at 28.79 USD - Investing.com
NCCN’s Myeloma MRD Update Spotlighting clonoSEQ Could Be A Game Changer For Adaptive Biotechnologies (ADPT) - Yahoo Finance
Adaptive Biotechnologies (ADPT): Can Blood Cancer Guidelines Boost Repeat Testing? - Insider Monkey
Adaptive Biotechnologies (NASDAQ:ADPT) Price Target Raised to $34.00 at BTIG Research - MarketBeat
Adaptive Biotechnologies (NASDAQ:ADPT) Reaches New 1-Year HighShould You Buy? - MarketBeat
Tidal Investments LLC Takes $855,000 Position in Adaptive Biotechnologies Corporation $ADPT - MarketBeat
Adaptive Biotechnologies CPO Francis Lo sells $3.2m in stock - Investing.com
Adaptive Biotechnologies CPO Francis Lo sells $3.2m in stock By Investing.com - Investing.com Canada
Adaptive Biotechnologies (ADPT) HR chief sells over 100,000 shares under preset plan - Stock Titan
Adaptive Biotechnologies Corp (ADPT) Key Financial Ratios – Valuation, Profitability & More - Value Research
Adaptive biotechnologies chief commercial officer sells $32,265 in shares. - Investing.com
Adaptive Biotechnologies (NASDAQ:ADPT) Insider Sells 1,195 Shares - MarketBeat
Adaptive Biotechnologies (NASDAQ: ADPT) CCO sells shares under pre-set trading plan - Stock Titan
ADPT Looks 137.6% Overvalued on GF Value™ - gurufocus.com
Adaptive Biotechnologies Announces Update to NCCN Guidelines® for Multiple Myeloma, Strengthening MRD Testing Recommendations and Specifically Referencing clonoSEQ® - Yahoo Finance
Alert incorrectly tagged to Adaptive Biotechnologies withdrawn - marketscreener.com
Adaptive Biotechnologies Corporation (NASDAQ:ADPT) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat
Adaptive Biotechnologies (ADPT) officer to sell 142K shares - Stock Titan
Adaptive Biotechnologies (NASDAQ:ADPT) Hits New 52-Week HighTime to Buy? - MarketBeat
A Look at Adaptive Biotechnologies Corp (ADPT) After 7.7% Gain -- GF Value $11.66 vs Price $26.68 - gurufocus.com
Officer at Adaptive Biotechnologies (NASDAQ: ADPT) plans sale of 1,195 shares - Stock Titan
Adaptive Biotechnologies stock hits 52-week high at 26.89 USD By Investing.com - Investing.com Nigeria
Adaptive Biotechnologies (NASDAQ:ADPT) Stock Price Up 6.4%What's Next? - MarketBeat
Adaptive Biotechnologies stock hits 52-week high at 26.89 USD - Investing.com
Adaptive Biotechnologies Corp (ADPT) Shareholding Pattern – Promoters, FIIs & DIIs - valueresearchonline.com
Adaptive Biotechnologies (NASDAQ: ADPT) director reports stock gift, still holds 66,100 shares - Stock Titan
Adaptive Biotechnologies to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference - The Manila Times
Morgan Stanley’s healthcare conference sets a biotech chat for Sept. 15 - Stock Titan
Adaptive Biotechnologies Corp (ADPT) Peer Comparison – Compare with Others - Value Research
Adaptive Biotechnologies Corp (ADPT) Financials – Balance Sheet, Profit & Loss, Cash Flow - Value Research
Director Katey Owen Sells 9,615 Shares of Adaptive Biotechnologies Corp (ADPT) - GuruFocus
Adaptive Biotechnologies director Owen sells $249,990 in stock. By Investing.com - Investing.com India
Adaptive Biotechnologies director Owen sells $249,990 in stock. - Investing.com
Adaptive Biotechnologies stock hits 52-week high at $26.63 By Investing.com - Investing.com Nigeria
Adaptive Biotechnologies stock hits 52-week high at $26.63 - Investing.com
Adaptive Biotech (NASDAQ: ADPT) director lines up $249,990 stock sale - Stock Titan
Adaptive Biotechnologies Stock Has Doubled in the Past Year. Here’s What Could Come Next. - inkl
Bank of America Corp DE Acquires 421,645 Shares of Adaptive Biotechnologies Corporation $ADPT - MarketBeat
Adaptive Biotechnologies director Robert Hershberg sells $748k in shares - Investing.com
Adaptive Biotechnologies director Robert Hershberg sells $748k in shares By Investing.com - Investing.com South Africa
Adaptive Biotechnologies (NASDAQ:ADPT) Director Robert Hershberg Sells 30,664 Shares of Stock - MarketBeat
Adaptive Biotechnologies Director Robert Hershberg Executes Stock Option and Sells Shares - Kalkine Media
Adaptive Biotech (NASDAQ: ADPT) ex-officer to sell 402,160 shares - Stock Titan
Adaptive Biotechnologies (NASDAQ: ADPT) director exercises option at $6.32 strike - Stock Titan
Adaptive Biotechnologies director Neupert sells $3.1m in stock By Investing.com - Investing.com Nigeria
Adaptive Biotechnologies CEO Chad Robins sells $14.88m in shares By Investing.com - Investing.com India
Adaptive Biotechnologies director Neupert sells $3.1m in stock - Investing.com
Adaptive Biotechnologies CEO Chad Robins sells $14.88m in shares - Investing.com
Adaptive Biotechnologies (NASDAQ:ADPT) CEO Chad Robins Sells 278,676 Shares - MarketBeat
Adaptive Biotechnologies (ADPT) CEO sells 600K shares after exercising options - Stock Titan
0.23%
0.01%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):